Results schedulesBSE · 544445
Asston Pharmaceuticals Ltd
Asston Pharmaceuticals Ltd - 544445 - Board Meeting Intimation for To Consider And Approve The Following Matters As Attached
01 / The disclosure
What the company shared
Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve matters as attached
Exchange-provided summary Company profile
A question for your research
Confirm the meeting date and reporting period. A scheduled meeting or trading-window closure does not establish that results have been released.
The evidence
Read the source excerpts
PDF text extraction is queued. The summary above comes from the exchange listing.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 6afb0f2c-8415-4f6f-8e2c-cf6a149ad66c
- First collected
- 6 Oct 2026, 20:58 IST
- PDF extraction
- pending
You’ve reached the end of this disclosure.